Targeted mesenchymal stem cell and vascular endothelial growth factor strategies for repair of nerve defects with nerve tissue implanted autogenous vein graft conduits

Fıkret Eren,Sınan Öksüz,Zafer Küçükodaci,Mustafa Tansel Kendırlı,Ceyhun Cesur,Emıne Alarçın,Ezgı ırem Bektaş,Hüseyın Karagöz,Oya Kerımoğlu,Gamze Torun Köse,Ersın Ülkür,Vijay Gorantla

DOI: https://doi.org/10.1002/micr.22401

2015-04-13

Microsurgery

Abstract:Peripheral nerve gaps exceeding 1 cm require a bridging repair strategy. Clinical feasibility of autogenous nerve grafting is limited by donor site comorbidity. In this study we investigated neuroregenerative efficacy of autogenous vein grafts implanted with tissue fragments from distal nerve in combination with vascular endothelial growth factor (VEGF) or mesenchymal stem cells (MSCs) in repair of rat peripheral nerve defects. Six-groups of Sprague-Dawley rats (n = 8 each) were evaluated in the autogenous setting using a 1.6 cm long peroneal nerve defect: Empty vein graft (group 1), Nerve graft (group 2), Vein graft and nerve fragments (group 3), Vein graft and nerve fragments and blank microspheres (group 4), Vein graft and nerve fragments and VEGF microspheres (group 5), Vein graft and nerve fragments and MSCs (group 6). Nerve fragments were derived from distal segment. Walking track analysis, electrophysiology and nerve histomorphometry were performed for assessment. Peroneal function indices (PFI), electrophysiology (amplitude) and axon count results for group 2 were -9.12 ± 3.07, 12.81 ± 2.46 mV, and 1697.88 ± 166.18, whereas the results for group 5 were -9.35 ± 2.55, 12.68 ± 1.78, and 1566 ± 131.44, respectively. The assessment results did not reveal statistical difference between groups 2 and 5 (P > 0.05). The best outcomes were seen in group 2 and 5 followed by group 6. Compared to other groups, poorest outcomes were seen in group 1 (P ≤ 0.05). PFI, electrophysiology (amplitude) and axon count results for group 1 were -208.82 ± 110.69, 0.86 ± 0.52, and 444.50 ± 274.03, respectively. Vein conduits implanted with distal nerve-derived nerve fragments improved axonal regeneration. VEGF was superior to MSCs in facilitating nerve regeneration. © 2015 Wiley Periodicals, Inc. Microsurgery 36:578-585, 2016.

surgery

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: how to effectively repair peripheral nerve defects, especially nerve gaps exceeding 1 centimeter. Specifically, the study explored the nerve regeneration effect of using autologous vein grafts combined with distal nerve tissue fragments and vascular endothelial growth factor (VEGF) or mesenchymal stem cells (MSCs) in repairing peripheral nerve defects in rats. The study aimed to find an alternative to autologous nerve grafts in order to reduce donor - site complications while improving the effect of nerve regeneration.

The research background indicates that for peripheral nerve defects exceeding 1 centimeter, a bridging repair strategy is required. Although autologous nerve grafts are clinically feasible, they are limited by donor - site complications, such as pain, the risk of neuroma, loss of motor or sensory function, and lack of sufficient nerve length. Therefore, the research team designed an experiment to evaluate the effects of different treatment methods through six different groups, including empty vein grafts, nerve grafts, vein grafts plus nerve fragments, vein grafts plus nerve fragments and blank microspheres, vein grafts plus nerve fragments and VEGF microspheres, and vein grafts plus nerve fragments and MSCs.

The main purpose of the study was to compare the effects of these different treatment methods on nerve regeneration, especially focusing on the effects of VEGF and MSCs in promoting nerve regeneration. The nerve function recovery of each group was evaluated by methods such as gait analysis, electrophysiological tests, and nerve tissue morphology measurement. The results showed that the nerve regeneration effect in the VEGF microsphere group was comparable to that in the autologous nerve graft group, while the effect in the MSCs group was slightly inferior. This indicates that VEGF may have a better effect in promoting nerve regeneration, especially in maintaining the patency of the venous lumen and promoting axon growth.

Overall, this study provides a new idea for solving the problem of peripheral nerve defect repair, especially in reducing donor - site complications while improving the effect of nerve regeneration.